- Blockers have a class 1a recommendation in the treatment of patients with ST-elevation myocardial infarctions ( STEMIs ) , as they are associated with a reduced mortality , recurrent myocardial infarction , life-threatening arrhythmias , and with prevention of unfavorable left ventricular remodeling .